Catheter Stabilization Devices Market Size, Share & Industry Analysis By Product (Arterial Securement Devices, CVC Securement Devices, Peripheral Securement Devices, Urinary Catheters Securement Devices, Chest Drainage Tubes Securement Devices, and Others), By Application (Cardiovascular Procedures, Respiratory Procedures, General Surgery, Gastric Procedures, Urological Procedures, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global catheter stabilization devices market is experiencing significant growth due to the high volume of intravenous access placements in surgeries, oncology, emergency care, and dialysis settings, increasing the demand for catheter securement. Moreover, the aging population is contributing to higher disease prevalence, propelling the demand for procedures that involve the use of catheter stabilization devices.

Catheter Stabilization Devices Market Driver

Rising Incidence of Hospital-Acquired Infections (HAIs) and Catheter-Related Complications to Propel the Market Growth

Over the past few years, there have been an increasing number of cases of CLABSI (Central Line-Associated Bloodstream Infections) and catheter dislodgement, which have prompted hospitals to adopt high-quality stabilization devices. Additionally, regulatory and accreditation bodies are emphasizing the securement of catheters as a critical step in IV therapy safety, which is anticipated to drive market growth during the forecast period.

• For instance, according to data from the Agency for Healthcare Research and Quality, in December 2025, ICU patients face an elevated risk of CLABSI, with 48.0% requiring indwelling central venous catheters that contribute to approximately 15 million central line days annually across ICUs in the U.S.

Download Free sample to learn more about this report.

According to data published by the Agency for Healthcare Research and Quality in January 2024, in the U.S., about 1 in every 31 hospitalized patients acquires a healthcare-associated infection (HAI), resulting in roughly 633,300 new cases each year.

Catheter Stabilization Devices Market Restraint

Skin Irritation and Adhesive-Related Complications to Hinder the Market Growth

Despite the increasing demand for catheter stabilization devices, some patients experience contact dermatitis, skin tears, or maceration from adhesive-based securement products. This is leading to reluctance among clinicians, especially for elderly, neonatal, and ICU patients with fragile skin, thereby hampering the market expansion in the upcoming years.

Catheter Stabilization Devices Market Opportunity

Rising Shift toward Suture-Free & Integrated Securement Solutions to Offer Lucrative Growth Opportunity

In recent years, hospitals have increasingly adopted sutureless securement systems to eliminate needle-stick risks and enhance infection control. Additionally, integrated securement devices built into catheters (ISDs) are also expected to provide long-term opportunities for device manufacturers, supporting market expansion in the forthcoming years.

• For instance, in August 2020, Delta Med's Alfalock sutureless stabilization systems are designed to accommodate all types of central, peripheral, and arterial venous catheters on the market.

Segmentation

Key Insights

The report covers the following key insights:

• Number of Key Surgeries, by Key Countries/Region, 2025
• Technological Advancements in Catheter Stabilization Devices
• Key Industry Developments - (Mergers, Acquisitions & Partnerships, and Others)

Analysis by Product

Based on product, the market is categorized into arterial securement devices, CVC securement devices, peripheral securement devices, urinary catheters securement devices, chest drainage tubes securement devices, and others.

The arterial securement devices segment is expected to account for the largest market share during the forecast period. These devices are used for arterial lines in the ICU, emergency care, and perioperative monitoring. Its adoption is increasing due to a surge in hemodynamic monitoring and critical care admissions, especially in developed markets, which is expected to fuel the market’s growth.

Analysis by Application

The market, by application is divided into cardiovascular procedures, respiratory procedures, general surgery, gastric procedures, urological procedures, and others.

The cardiovascular procedures segment is expected to hold a major share during the projection period. The growth is attributed to the increasing prevalence of cardiovascular diseases, requiring cardiac surgeries and catheter placements. This is driving the usage of arterial lines and central lines in such procedures.

• For instance, in September 2025, data from the National Center for Biotechnology Information (NCBI) reported an overall CAD prevalence of 4.6% to 4.9% in the U.S. population.

Analysis by End-user

By end-user, the market has been segmented into hospitals & ASCs, specialty clinics, and others.

The hospitals segment held the largest market share in 2025. The majority of catheter placements (IV, CVC, urinary, and arterial) are primarily performed in hospital settings due to high ICU admissions and the availability of specialized expertise. This is driving the adoption of advanced, suture-free securement systems due to stricter safety protocols in these settings.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

North America held the largest global market share for catheter stabilization devices in 2025. The growth is attributed to high catheter utilization in hospitals and ambulatory centers, supported by a strong regulatory focus on infection prevention in the region. Moreover, the growth of ambulatory surgery centers is contributing to a high surgical volume, increasing the demand for catheter stabilization devices in the region.

• For instance, according to data from MedPAC, the number of Medicare-certified ambulatory surgery centers (ASCs) increased by 2.5% between 2022 and 2023, reaching 6,308 facilities.

Asia Pacific is expected to grow at the highest CAGR over the forecast period. The growth is attributed to an aging population, which is increasing the risk of cardiovascular diseases and driving the demand for catheterization procedures. This is further expected to drive the demand for catheter stabilization devices in the upcoming years.

Key Players Covered

The global catheter stabilization devices market is fragmented, with key companies focusing on new product launches, collaborations, acquisitions, increased investments, and expanding their geographic reach to enhance their market position.

The report includes the profiles of the following key players:

• BD (U.S.)
• ICU Medical, Inc. (U.S.)
• Braun SE (Germany)
• Merit Medical Systems (U.S.)
• Cardinal Health (U.S.)
• Baxter (U.S.)
• Hollister Incorporated (U.S.)
• Medline Industries, LP. (U.S.)
• Dale Medical Products, Inc. (U.S.)
• Vygon (France)

Key Industry Developments

• November 2025: Cathetrix launched Nephro-Safe, an advanced nephrostomy tube stabilizer from its sister company, TubeX, at MEDICA 2025. The product features secure anchoring and anti-slide technology to prevent dislodgement and infections. The company showcased Foley-Safe, the first active Foley catheter stabilizer featuring 14-day adhesive fixation, an anti-slide mechanism, and emergency disconnection, designed to reduce CAUTIs and trauma.
• December 2023: Levity Products launched the revolutionary LECS (Levity External Catheter Stabilizer) family, FDA-cleared Class I devices that feature hypoallergenic adhesives for up to 7 days of secure catheter attachment, thereby reducing migration, friction, and infection risks.